Hearing and balance technology readers will find an inviting industry piece on a company's strategic expansion and shifting R&D focus for auditory care.
Key Takeaways
- MED-EL acquired two gene therapy programs from Rescue Hearing
- Programs target genetic disorders linked to MYO7A and STRC gene mutations
- One program addresses MYO7A-linked balance disorders and the other addresses STRC-related hearing loss